As plans for PEPFAR's future move forward, up to 2 million people in lower-income countries will receive Gilead Sciences' HIV prevention drugs. Meanwhile, the Atlanta Journal-Constitution reports how reinstated CDC staff were tasked with dismantling their own departments, including the Division of HIV Prevention. Stat: Trump Administration Confirms Plan For PEPFAR To Distribute Gilead's New HIV Prevention Drug After months of uncertainty, the Trump administration confirmed that it will work with Gilead Sciences and The Global Fund to Fight AIDS, Tuberculosis and Malaria to provide a groundbreaking HIV prevention drug to up to 2 million people in low- and middle-income...